AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for…
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…
Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth…
MUNICH, Aug. 4, 2025 /PRNewswire/ -- Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider,…
INDIANAPOLIS, Aug. 4, 2025 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is…
Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates…
August 04, 2025 06:00 ET | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE)…
PMI ranks No. 4 in the line-up of global net zero leaders, marking its third consecutive year on Forbes' annual…
August 01, 2025 16:55 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE)…
IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic…